Ultragenyx Pharmaceutical Inc
(MEX:RARE)
MXN
751.98
0 (0%)
Market Cap: 65.87 Bil
Enterprise Value: 59.05 Bil
PE Ratio: 0
PB Ratio: 23.46
GF Score: 70/100 - Q1 2024 Ultragenyx Pharmaceutical Inc Earnings Call TranscriptMay 02, 2024MXN751.98Earnings
- Ultragenyx Pharmaceutical Inc at TD Cowen Health Care Conference TranscriptMar 04, 2024
- Q4 2023 Ultragenyx Pharmaceutical Inc Earnings Call TranscriptFeb 15, 2024MXN751.98Earnings
- Ultragenyx Pharmaceutical Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Ultragenyx Pharmaceutical Inc at Piper Sandler Healthcare Conference TranscriptNov 29, 2023
- Ultragenyx Pharmaceutical Inc at Jefferies London Healthcare Conference TranscriptNov 14, 2023
- Q3 2023 Ultragenyx Pharmaceutical Inc Earnings Call TranscriptNov 02, 2023MXN594.48Earnings
- Ultragenyx Pharmaceutical Inc Present Pipeline Update at Analyst Day TranscriptOct 16, 2023
- Ultragenyx Pharmaceutical Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Ultragenyx Pharmaceutical Inc at Citi BioPharma Conference TranscriptSep 06, 2023
- Q2 2023 Ultragenyx Pharmaceutical Inc Earnings Call TranscriptAug 03, 2023MXN735.34Earnings
- Ultragenyx Pharmaceutical Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Ultragenyx Pharmaceutical Inc SETRUSUMAB Phase 2 Data Conference Call TranscriptJun 05, 2023
- Ultragenyx Pharmaceutical Inc at Barclays Virtual Gene Editing & Therapy Summit TranscriptMay 24, 2023
- Ultragenyx Pharmaceutical Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Ultragenyx Pharmaceutical Inc Earnings Call TranscriptMay 04, 2023MXN775.77Earnings
- Ultragenyx Pharmaceutical Inc at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days (Virtual) TranscriptApr 03, 2023
- Ultragenyx Pharmaceutical Inc at Cowen Health Care Conference- Orphan CNS Panel Discussion TranscriptMar 07, 2023
- Q4 2022 Ultragenyx Pharmaceutical Inc Earnings Call TranscriptFeb 16, 2023MXN873.23Earnings
- Ultragenyx Pharmaceutical Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Ultragenyx Pharmaceutical Inc at Piper Sandler Healthcare Conference TranscriptNov 29, 2022
- Ultragenyx Pharmaceutical Inc at Jefferies London Healthcare Conference TranscriptNov 17, 2022
- Ultragenyx Pharmaceutical Inc at Stifel Healthcare Conference TranscriptNov 15, 2022
- Q3 2022 Ultragenyx Pharmaceutical Inc Earnings Call TranscriptNov 02, 2022MXN810.85Earnings
- Rocket Pharmaceuticals Inc, Decibel Therapeutics Inc and Ultragenyx Pharmaceutical Inc at Citi BioPharma Conference- Panel TranscriptSep 07, 2022
- Q2 2022 Ultragenyx Pharmaceutical Inc Earnings Call TranscriptJul 28, 2022MXN931.97Earnings
- Ultragenyx Pharmaceutical Inc and GeneTx Biotherapeutics LLC GTX-102 Interim Data and Program Update Call TranscriptJul 18, 2022
- Ultragenyx Pharmaceutical Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 16, 2022
- Ultragenyx Pharmaceutical Inc at Jefferies Healthcare Conference TranscriptJun 08, 2022
- Ultragenyx Pharmaceutical Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Q1 2022 Ultragenyx Pharmaceutical Inc Earnings Call TranscriptMay 05, 2022MXN1393.25Earnings
- Ultragenyx Pharmaceutical Inc, Alector Inc, Passage Bio Inc, AVROBIO Inc and Annexon Inc in the Orphan CNS Panel at Cowen Health Care Conference (Virtual) TranscriptMar 08, 2022
- Q4 2021 Ultragenyx Pharmaceutical Inc Earnings Call TranscriptFeb 10, 2022MXN1472.7Earnings
- Ultragenyx Pharmaceutical Inc at H C Wainwright Bioconnect Conference (Virtual) TranscriptJan 13, 2022
- Ultragenyx Pharmaceutical Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Ultragenyx Pharmaceutical Inc at Evercore ISI HealthCONx Virtual Conference TranscriptDec 01, 2021
- Q3 2021 Ultragenyx Pharmaceutical Inc Earnings Call TranscriptNov 02, 2021Earnings
- Ultragenyx Pharmaceutical Inc at Jefferies Gene Therapy/Editing Summit (Virtual) TranscriptOct 28, 2021
- Ultragenyx Pharmaceutical Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
- Ultragenyx Pharmaceutical Inc Finding a Needle in a Haystack - Drug Development Strategies for Rare Disease Panel at Citi BioPharma Conference (Virtual) TranscriptSep 09, 2021
- Ultragenyx Pharmaceutical Inc Miss Con-GENE-iality - Updates in Gene Tx Panel at Wedbush PacGrow Healthcare Conference (Virtual) TranscriptAug 11, 2021
- Q2 2021 Ultragenyx Pharmaceutical Inc Earnings Call TranscriptAug 02, 2021MXN1692Earnings
- Ultragenyx Pharmaceutical Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2021
- Ultragenyx Pharmaceutical Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 12, 2021
- Q1 2021 Ultragenyx Pharmaceutical Inc Earnings Call TranscriptMay 04, 2021MXN2253.8Earnings
- Pfizer Inc, Avidity Biosciences, Sarepta Therapeutics, Solid Biosciences, and Ultragenyx Pharmaceutical at Guggenheim Partners Healthcare Talks: Genomic Medicines & Rare Disease (Virtual) TranscriptApr 01, 2021
- Ultragenyx Pharmaceutical Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 10, 2021
- Ultragenyx Pharmaceutical Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 01, 2021
- Q4 2020 Ultragenyx Pharmaceutical Inc Earnings and Corporate Update Call TranscriptFeb 11, 2021
- Ultragenyx Pharmaceutical Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Ultragenyx Pharmaceutical Inc at Barclays Virtual Gene Editing & Gene Therapy Summit TranscriptNov 16, 2020
- Ultragenyx Pharmaceutical Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 10, 2020
- Q3 2020 Ultragenyx Pharmaceutical Inc Earnings Call TranscriptOct 27, 2020MXN1908.5Earnings
- Ultragenyx Pharmaceutical Inc GTX-102 Data Update Call TranscriptOct 26, 2020
- Ultragenyx Pharmaceutical Inc at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- Ultragenyx Pharmaceutical Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2020
- Eiger BioPharmaceuticals Inc, Applied Therapeutics, Ultragenyx Pharmaceutical, Dicerna Pharmaceuticals, and Imara Inc at Citi BioPharma Conference (Virtual) - Panel TranscriptSep 09, 2020
- Q2 2020 Ultragenyx Pharmaceutical Inc Earnings Call TranscriptJul 30, 2020MXN1911.15Earnings
- Ultragenyx Pharmaceutical Inc Dojolvi US FDA Approval Call TranscriptJun 30, 2020
- Ultragenyx Pharmaceutical Inc Annual Shareholders Meeting TranscriptJun 26, 2020
- Ultragenyx Pharmaceutical Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2020
- Ultragenyx Pharmaceutical Inc ASGCT DTX301 and DTX401 Data Updates Call TranscriptMay 15, 2020
- Ultragenyx Pharmaceutical Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 14, 2020
- Q1 2020 Ultragenyx Pharmaceutical Inc Earnings Call TranscriptMay 06, 2020MXN1323.83Earnings
- Ultragenyx Pharmaceutical Inc in Virtual Presentation at Barclays Global Healthcare Conference TranscriptMar 11, 2020
- Q4 2019 Ultragenyx Pharmaceutical Inc Earnings Call TranscriptFeb 13, 2020MXN1120.15Earnings
- Ultragenyx Pharmaceutical Inc at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- Ultragenyx Pharmaceutical Inc DTX301 Phase 1/2 Study in Ornithine Transcarbamylase (OTC) Deficiency Cohort 2 and 3 Data Update TranscriptJan 09, 2020
- Ultragenyx Pharmaceutical Inc at Credit Suisse Healthcare Conference - Scottsdale TranscriptNov 12, 2019
- Q3 2019 Ultragenyx Pharmaceutical Inc Earnings Call TranscriptNov 05, 2019MXN876.8Earnings
- Ultragenyx Pharmaceutical Inc at Jefferies Gene Therapy/Editing Summit TranscriptOct 08, 2019
- Ultragenyx Pharmaceutical Inc at Morgan Stanley Healthcare Conference TranscriptSep 11, 2019
- Ultragenyx Pharmaceutical Inc Ultragenyx DTX401 Phase 1/2 Cohort 2 Data Conference Call TranscriptSep 04, 2019
- Q2 2019 Ultragenyx Pharmaceutical Inc Earnings Call TranscriptAug 01, 2019Earnings
- Ultragenyx Pharmaceutical Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 13, 2019
- Ultragenyx Pharmaceutical Inc Annual Shareholders Meeting TranscriptJun 11, 2019
- Ultragenyx Pharmaceutical Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- Q1 2019 Ultragenyx Pharmaceutical Inc Earnings Call TranscriptMay 06, 2019Earnings
- Ultragenyx Pharmaceutical Inc Analyst and Investor Day TranscriptApr 17, 2019
- Ultragenyx Pharmaceutical Inc at Barclays Global Healthcare Conference TranscriptMar 13, 2019
- Ultragenyx Pharmaceutical Inc at Cowen and Company Health Care Conference TranscriptMar 12, 2019
- Q4 2018 Ultragenyx Pharmaceutical Inc Earnings Call TranscriptFeb 19, 2019Earnings
Ultragenyx Pharmaceutical Inc at Jefferies London Healthcare Conference Transcript
Nov 17, 2022 / 10:25AM GMT
Release Date Price:
MXN669.19
(+0.42%)
Farzin Haque
Jefferies LLC, Research Division - Equity Associate
Hi, everyone. My name is Farzin Haque. I'm an associate from Morris team at Jefferies. It's a pleasure to welcome Emil Kakkis, CEO of Ultragenyx. I think he has a few slides to start off with.
Emil D. Kakkis
Ultragenyx Pharmaceutical Inc. - Founder, President, CEO & Director
Yes.
Farzin Haque
Jefferies LLC, Research Division - Equity Associate
Welcome.
Emil D. Kakkis
Ultragenyx Pharmaceutical Inc. - Founder, President, CEO & Director
Thank you for having me. It's good to be in London. It's been so long since I've been in London. Walking around Covent Garden, been a while, it's been in a long time, too long. Happy to be here in London again, one of my favorite places and talk to you a little about where Ultragenyx is.
12 years ago with me and my secretary, couple of million dollars, and this is where we are today. With the commercial franchise, there is a forward-looking statement,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)